Improved laboratory diagnostics of lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid

Pediatric Infectious Disease Journal

Volumn 27, Issue 7, 2008, Pages 605-612

  Skogman, Barbro H ^a,b   Croner, Stefan ^a   Forsberg, Pia ^a   Ernerudh, Jan ^a   Lahdenne, Pekka ^c   Sillanpää, Heidi ^d   Seppälä, Ilkka ^d,e  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Center for Clinical Research Dalarna   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cerebrospinal fluid; Diagnostic test; Lyme disease; Neuroborreliosis; Recombinant proteins

Indexed keywords

DECORIN BINDING PROTEIN A; IMMUNOGLOBULIN G ANTIBODY; INVARIABLE REGION 6 PEPTIDE; OUTER SURFACE PROTEIN C; PROTEIN BBK32; RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ADHESIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CYCLIC PEPTIDE 24 41C; CYCLIC PEPTIDE 24-41C; CYCLOPEPTIDE; DDPB PROTEIN, BORRELIA BURGDORFERI; DIAGNOSTIC AGENT; OSPC PROTEIN; OUTER MEMBRANE PROTEIN; P35 ANTIGEN, BORRELIA;

ANTIBODY DETECTION; ARTICLE; BACTERIAL FLAGELLUM; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY DIAGNOSIS; LYME DISEASE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; ADULT; CEREBROSPINAL FLUID; EVALUATION; GENETICS; IMMUNOLOGY; METHODOLOGY; SYNTHESIS;

ADHESINS, BACTERIAL; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; BORRELIA BURGDORFERI GROUP; CEREBROSPINAL FLUID; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYME NEUROBORRELIOSIS; PEPTIDES, CYCLIC; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 50949131771     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31816a1e29     Document Type: Article

References (62)

1. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362:1639-1647.
2. Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev. 1999;12:633-653.
3. Steere AC. Lyme disease. N Engl J Med. 1989;321:586-596.
4. Steere AC. Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut. Wien Klin Wochenschr. 2006;118:625-633.
5. Fraenkel CJ, Garpmo U, Berglund J. Determination of novel Borrelia genospecies in Swedish Ixodes ricinus ticks. J Clin Microbiol. 2002;40: 3308-3312.
6. van Dam AP, Kuiper H, Vos K, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993;17708-17717.
7. Sood SK. What we have learned about Lyme borreliosis from studies in children. Wien Klin Wochenschr. 2006;118:638-642.
8. Oschmann P, Dorndorf W, Hornig C, Schafer C, Wellensiek HJ, Pflughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol. 1998;245:262-272.
9. Vrethem M, Hellblom L, Widlund M, et al. Chronic symptoms are common in patients with neuroborreliosis-a questionnaire follow-up study. Acta Neurol Scand. 2002;106:205-208.
10. Christen HJ, Hanefeld F, Eiffert H, Thomssen R. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl. 1993;386:1-75.
11. Huppertz HI. Lyme disease in children. Curr Opin Rheumatol. 2001;13: 434-440.
12. Eppes SC. Diagnosis, treatment, and prevention of Lyme disease in children. Paediatr Drugs. 2003;5:363-372.
13. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-yr follow-up study of patients with neuroborreliosis. Scand J Infect Dis. 2002;34:421-425.
14. Stiernstedt G, Gustafsson R, Karlsson M, Svenungsson B, Skoldenberg B. Clinical manifestations and diagnosis of neuroborreliosis. AnnNY Acad Sci. 1988;539:46-55.
15. DePietropaolo DL, Powers JH, Gill JM, Foy AJ. Diagnosis of lyme disease. Am Fam Physician. 2005;72:297-304.
16. Bryant KA, Marshall GS. Clinical manifestations of tick-borne infections in children. Clin Diagn Lab Immunol. 2000;7:523-527.
17. Ledue TB, Collins MF, Craig WY. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J Clin Microbiol. 1996;34:2343-2350.
18. Brouqui P, Bacellar F, Baranton G, Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect. 2004;10: 1108-1132.
19. van Dam AP. Recent advances in the diagnosis of Lyme disease. Expert Rev Mol Diagn. 2001;1:413-427.
20. Wilske B. Diagnosis of lyme borreliosis in europe. Vector Borne Zoonotic Dis. 2003;3:215-227.
21. Wilske B. Epidemiology and diagnosis of Lyme borreliosis. Ann Med. 2005;37:568-579.
22. Blanc F, Jaulhac B, Fleury M. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology. 2007;69:953-958.
23. Keller TL, Halperin JJ, Whitman M. PCR detection of Borrelia burg-dorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology. 1992;42:32-42.
24. Lebech AM, Hansen K, Brandrup F, Clemmensen O, Halkier-Sørensen L. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn. 2000;5:139-150.
25. Avery RA, Frank G, Eppes SC. Diagnostic utility of Borrelia burgdorferi cerebrospinal fluid polymerase chain reaction in children with Lyme meningitis. Pediatr Infect Dis J. 2005;24:705-708.
26. Pícha D, Moravcova ́ L, Zdárský E, Maresova ́ V, Hulínský V. PCR in lyme neuroborreliosis: a prospective study. Acta Neurol Scand. 2005; 27.
27. Goossens HA, van den Bogaard AE, Nohlmans MK. Evaluation of fifteen commercially available serological tests for diagnosis of Lyme borreliosis. Eur J Clin Microbiol Infect Dis. 1999;18:551-560.
28. Ekerfelt C, Ernerudh J, Forsberg P. Lyme borreliosis in Sweden-diagnostic performance of five commercial Borrelia serology kits using sera from well-defined patient groups. APMIS. 2004;112:74-78.
29. Bacon RM, Biggerstaff BJ, Schriefer ME. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis. 2003;187:1187-1199.
30. Blaauw AA, van Loon AM, Schellekens JF, Bijlsma JW. Clinical evaluation of guidelines and two-test approach for lyme disease. Rheumatology (Oxford). 1999;38:1121-1126.
31. Heikkilä T, Seppa ̈la ̈ I, Saxen H, Panelius J, Yrja ̈na ̈inen H, Lahdenne P. Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A. J Clin Microbiol. 2002;40:453-460.
32. Panelius J, Lahdenne P, Saxen H, et al. Diagnosis of Lyme neurobor-reliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and Vlse IR6 peptide. J. Neurol. 2002;250:1318-1327.
33. Heikkila ̈ T, Saxen H, Seppäla ̈I,Lonnqvist T, Sillanpa ̈a ̈ H, Lahdenne P. New antigens for serologic diagnosis of neuroborreliosis in children. Pediatr Infect Dis J. 2005;24:709-712.
34. Schulte-Spechtel U, Lehnert G, Liegl G, et al. Significant improvement of the recombinant Borrelia IgG immunoblot for serodiagnosis of early neuroborreliosis. Int J Med Microbiol. 2004;293(Suppl 37):158-160.
35. Goettner G, Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B, Fingerle V. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J Clin Microbiol. 2005;43:3602-3609.
36. Panelius J, Sillanpa ̈a ̈ H, Seppa ̈la ̈ I, Sarvas H, Lahdenne P. Antibodies to recombinant decorin-binding proteins A and B in the cerebrospinal fluid of patients with Lyme neuroborreliosis. Scand J Infect Dis. 2007;39: 775-780.
37. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology. 2005;65:448-450.
38. Fikrig E, Coyle PK, Schutzer SE, Chen M, Deng Z, Flavell RA. Preferential presence of decorin-binding protein B (BBA25) and BBA50 antibodies in cerebrospinal fluid of patients with neurologic Lyme disease. J Clin Microbiol. 2004;42:1243-1246.
39. Schulte-Spechtel U, Lehnert G, Liegl G, et al. Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. J Clin Microbiol. 2003; 41:1299-1303.
40. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol. 1999; 37:3990-3996.
41. Peltomaa M, McHugh G, Steere AC. The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis. Otol Neurotol. 2004;25:838-841.
42. Philipp MT, Marques AR, Fawcett PT, Dally LG, Martin DS. C6 test as an indicator of therapy outcome for patients with localized or disseminated lyme borreliosis. J Clin Microbiol. 2003;41:4955-4960.
43. Skarpaas T, Ljøstad U, Søbye M, Mygland A. Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis. 2007;26:675-677.
44. Pohl-Koppe A, Kaunicnik A, Wilske B. Characterization of the cellular and humoral immune response to outer surface protein C and outer surface protein 17 in children with early disseminated Lyme borreliosis. Med Microbiol Immunol (Berl). 2001;189:193-200.
45. Widhe M, Skogman BH, Jarefors S, et al. Up-regulation of Borrelia-specific IL-4- and IFN-gamma-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis. Int Immunol. 2005;17:1283-1291.
46. Holt PG. Postnatal maturation of immune competence during infancy and childhood. Pediatr Allergy Immunol. 1995;6:59-70.
47. Treatment and Prevention of Tick Borne Infections. Medical Products Agency (MPA); 1998;2:38-39.
48. Junttila J, Peltomaa M, Soini H, Marjamaki M, Viljanen MK. Prevalence of Borrelia burgdorferi in Ixodes ricinus ticks in urban recreational areas of Helsinki. J Clin Microbiol. 1999;37:1361-1365.
49. Heikkila T, Seppala I, Saxen H, et al. Recombinant BBK32 protein in serodiagnosis of early and late Lyme borreliosis. J Clin Microbiol. 2002;40:1174-1180.
50. Heikkila T, Seppala I, Saxen H, et al. Cloning of the gene encoding the decorin-binding protein B (DbpB) in Borrelia burgdorferi sensu lato and characterisation of the antibody responses to DbpB in Lyme borreliosis. J Med Microbiol. 2002;51:641-648.
51. Panelius J, Lahdenne P, Heikkila T, Peltomaa M, Oksi J, Seppala I. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis. J Med Microbiol. 2002;51:731-739.
52. Lagal V, Postic D, Ruzic-Sabljic E, Baranton G. Genetic diversity among Borrelia strains determined by single-strand conformation polymorphism analysis of the ospC gene and its association with invasiveness. J Clin Microbiol. 2003;41:5059-5065.
53. Hansen K, Pii K, Lebech AM. Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a mu-capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella. J Clin Microbiol. 1991;29:166-173.
54. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol. 1991;30:197-205.
55. Seppa ̈la ̈ IJ, Kroneld R, Schauman K, Forsen KO, Lassenius R. Diagnosis of Lyme borreliosis: non-specific serological reactions with Borrelia burgdorferi sonicate antigen caused by IgG2 antibodies. J Med Microbiol. 1994;40:293-302.
56. Balmelli T, Piffaretti JC. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol. 1995;146:329-340.
57. Ekerfelt C, Ernerudh J, Forsberg P, Bergstrom S. Augmented intrathecal secretion of interferon-gamma in response to Borrelia garinii in neuroborreliosis. J Neuroimmunol. 1998;89:177-181.
58. Kaiser R, Rauer S. Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto. Eur J Clin Microbiol Infect Dis. 1998;17:159-166.
59. Buckles EL, Earnhart CG, Marconi RT. Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development. Clin Vaccine Immunol. 2006;13:1162-1165.
60. Rubins S, Janniger CK, Schwartz RA. Congenital and acquired early childhood syphilis. Cutis. 1995;56:132-136.
61. Widhe M, Ekerfelt C, Forsberg P, Bergstrom S, Ernerudh J. IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an interferon-gamma-predominated disease. Scand J Immunol. 1998;47:575-581.
62. Forsberg P, Ernerudh J, Ekerfelt C, Roberg M, Vrethem M, Bergstrom S. The outer surface proteins of Lyme disease borrelia spirochetes stimulate T cells to secrete interferon-gamma (IFN-gamma): diagnostic and pathogenic implications. Clin Exp Immunol. 1995;101:453-460.